Literature DB >> 14596797

Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat.

Evripidis Gavathiotis1, Robert A Heald, Malcolm F G Stevens, Mark S Searle.   

Abstract

The NMR structure of the parallel-stranded DNA quadruplex d(TTAGGGT)(4), containing the human telomeric repeat, has been determined in solution in complex with a fluorinated pentacyclic quino[4,3,2-kl]acridinium cation (RHPS4). RHPS4 has been identified as a potent inhibitor of telomerase at submicromolar levels (IC(50) value of 0.33(+/-0.13)microM), exhibiting a wide differential between telomerase inhibition and acute cellular toxicity. All of the data point to RHPS4 exerting its chemotherapeutic potency through interaction with, and stabilisation of, four-stranded G-quadruplex structures. RHPS4 forms a dynamic interaction with d(TTAGGGT)(4), as evident from 1H and 19F linewidths, with fast exchange between binding sites induced at 318 K. Perturbations to DNA chemical shifts and 24 intermolecular nuclear Overhauser effects (NOEs) identify the 5'-ApG and 5'-GpT steps as the principle intercalation sites; a structural model has been refined using NOE-restrained molecular dynamics. The central G-tetrad core remains intact, with drug molecules stacking at the ends of the G-quadruplex. The partial positive charge on position 13-N of the acridine ring appears to act as a "pseudo" potassium ion and is positioned above the centre of the G-tetrad in the region of high negative charge density. In both ApG and GpT intercalation sites, the drug is seen to converge to the same orientation in which the pi-system of the drug overlaps primarily with two bases of each G-tetrad. The drug is held in place by stacking interactions with the G-tetrads; however, there is some evidence for a more dynamic, weakly stabilised A-tetrad that stacks partially on top of the drug at the 5'-end of the sequence. Together, the interactions of RHPS4 increase the t(m) of the quadruplex by approximately 20 degrees C. There is no evidence for drug intercalation within the G-quadruplex; however, the structural model strongly supports end-stacking interactions with the terminal G-tetrads.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596797     DOI: 10.1016/j.jmb.2003.09.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

1.  Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing.

Authors:  Yujian He; Ronald D Neumann; Igor G Panyutin
Journal:  Nucleic Acids Res       Date:  2004-10-08       Impact factor: 16.971

2.  Molecular dynamics studies of the 3D structure and planar ligand binding of a quadruplex dimer.

Authors:  Ming-Hui Li; Quan Luo; Xiang-Gui Xue; Ze-Sheng Li
Journal:  J Mol Model       Date:  2010-05-29       Impact factor: 1.810

Review 3.  DNA architecture: from G to Z.

Authors:  Anh Tuân Phan; Vitaly Kuryavyi; Dinshaw J Patel
Journal:  Curr Opin Struct Biol       Date:  2006-05-22       Impact factor: 6.809

4.  An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution.

Authors:  Jixun Dai; Thomas S Dexheimer; Ding Chen; Megan Carver; Attila Ambrus; Roger A Jones; Danzhou Yang
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

5.  Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs.

Authors:  William C Drewe; Rupesh Nanjunda; Mekala Gunaratnam; Monica Beltran; Gary N Parkinson; Anthony P Reszka; W David Wilson; Stephen Neidle
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

6.  Targeting human telomerase for cancer therapeutics.

Authors:  Lionel Guittat; Patrizia Alberti; Dennis Gomez; Anne De Cian; Gaëlle Pennarun; Thibault Lemarteleur; Chafke Belmokhtar; Rajaa Paterski; Hamid Morjani; Chantal Trentesaux; Eliane Mandine; François Boussin; Patrick Mailliet; Laurent Lacroix; Jean-François Riou; Jean-Louis Mergny
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

7.  New insights from molecular dynamic simulation studies of the multiple binding modes of a ligand with G-quadruplex DNA.

Authors:  Jin-Qiang Hou; Shuo-Bin Chen; Jia-Heng Tan; Hai-Bin Luo; Ding Li; Lian-Quan Gu; Zhi-Shu Huang
Journal:  J Comput Aided Mol Des       Date:  2012-12-13       Impact factor: 3.686

8.  G-quadruplex nucleic acids as therapeutic targets.

Authors:  Shankar Balasubramanian; Stephen Neidle
Journal:  Curr Opin Chem Biol       Date:  2009-06-08       Impact factor: 8.822

9.  Ruthenium Complex "Light Switches" that are Selective for Different G-Quadruplex Structures.

Authors:  Erin Wachter; Diego Moyá; Sean Parkin; Edith C Glazer
Journal:  Chemistry       Date:  2015-11-12       Impact factor: 5.236

10.  Verification of specific G-quadruplex structure by using a novel cyanine dye supramolecular assembly: II. The binding characterization with specific intramolecular G-quadruplex and the recognizing mechanism.

Authors:  Qianfan Yang; Junfeng Xiang; Shu Yang; Qian Li; Qiuju Zhou; Aijiao Guan; Xiufeng Zhang; Hong Zhang; Yalin Tang; Guangzhi Xu
Journal:  Nucleic Acids Res       Date:  2009-11-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.